8. Schrödinger Inc. (NASDAQ:SDGR)
Price: $11.79
All-time Low: $10.94
Upside: 69.64%
Schrödinger, Inc. stands out as one of the most compelling names on this list, particularly for investors seeking exposure to artificial intelligence in healthcare and biotech innovation. Trading at $11.79, near its all-time low of $10.94, the stock offers nearly 70% upside according to analyst estimates—one of the highest in this ranking.
The company operates at the cutting edge of computational drug discovery, leveraging software and AI to accelerate the development of new treatments. This dual model—combining software licensing with biotech pipelines—creates a diversified revenue stream that many early-stage biotech firms lack.
Looking ahead, the upcoming Q1 2026 earnings report and expected revenue of around $47.63 million will be closely watched. But the real story lies in the company’s strategic shift: transitioning 75% of software contracts to hosted models and targeting double-digit growth in annual contract value.
In a world increasingly driven by AI, Schrödinger is not just another biotech stock—it is a platform play in the future of drug discovery, making it one of the most intriguing high-upside growth stocks for 2026.
Click next to see the following stock...
